drugset / Trial / NCT05517993
Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension
RandomizedCrossoverSingle-blindTreatment
Summary
Intradialytic hypotension (IDH), a common complication during hemodialysis (HD) could increase patients' morbidity and mortality. Previous studies considered that some Chinese herbal medicine (CHM) plays a complementary role in reducing the frequency of IDH. This trial is aimed to investigate the effect of Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) in patients with intradialytic hypotension.
Timeline
- Start
- 2022-09-01
- Primary completion
- 2024-07-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gui-Lu-Er-Xian-Jiao-Wan | Traditional medicine (herbal / TCM) | 3 g | Oral |
Indications
No indication recorded.